BiotechTube
Home/Compugen/Anat Cohen-Dayag
AC

Anat Cohen-Dayag

Chief Executive Officer

Compugen

Therapeutic Areas

OncologyImmuno-oncology

Compugen Pipeline

DrugIndicationPhase
COM701 (anti-PVRIG)Advanced solid tumorsPhase 1/2
COM902 (anti-TIGIT)Advanced solid tumorsPhase 1
Bispecific Antibody ProgramsUndisclosed cancersPreclinical

Leadership Team at Compugen

HA
Henry Adewoye
Chief Financial Officer
MZ
Maytal Ziv
Chief Medical Officer
EO
Eran Ophir
Chief Scientific Officer
View full Compugen profile